验证数据展示
产品信息
19797-1-AP targets COL4A5 in WB, IHC, IF, ELISA applications and shows reactivity with human samples.
经测试应用 | ELISA Application Description |
文献引用应用 | WB, IHC, IF |
经测试反应性 | human |
文献引用反应性 | human, mouse, rat |
免疫原 | Peptide 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | collagen, type IV, alpha 5 |
别名 | Collagen alpha 5(IV) chain, Collagen alpha-5(IV) chain |
计算分子量 | 161 kDa |
GenBank蛋白编号 | NM_000495 |
基因名称 | COL4A5 |
Gene ID (NCBI) | 1287 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | P29400 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
COL4A5 belongs to the type IV collagen family. Type IV collagen is the major structural component of glomerular basement membranes (GBM), forming a 'chicken-wire' meshwork together with laminins, proteoglycans and entactin/nidogen. Defects in COL4A5 are the cause of Alport syndrome X-linked (APSX). Deletions covering the N-terminal regions of COL4A5 and COL4A6, which are localized in a head-to-head manner, are the cause of diffuse leiomyomatosis with Alport syndrome (DL-ATS)which also known as esophageal and vulval leiomyomatosis with nephropathy or Alport syndrome and diffuse leiomyomatosis (ATS-DL).
发表文章
Species | Application | Title |
---|---|---|
Biomaterials A novel bioscaffold with naturally-occurring extracellular matrix promotes hepatocyte survival and vessel patency in mouse models of heterologous transplantation. | ||
PLoS Genet Minor Type IV Collagen α5 Chain Promotes Cancer Progression through Discoidin Domain Receptor-1. | ||
FASEB J Drastic induction of MMP-7 by cortisol in the human amnion: implications for membrane rupture at parturition. | ||
Bioorg Chem AT1, a small molecular degrader of BRD4 based on proteolysis targeting chimera technology alleviates renal fibrosis and inflammation in diabetic nephropathy | ||
Sci Rep Methanol fixed fibroblasts serve as feeder cells to maintain stem cells in the pluripotent state in vitro. | ||
Front Pharmacol Sappanone a prevents diabetic kidney disease by inhibiting kidney inflammation and fibrosis via the NF-κB signaling pathway |